Comparison of cabergoline and intravenous albumin in the prevention of ovarian hyperstimulation syndrome: a randomized clinical trial

Low-Dose Dopamine Agonist Administration Blocks Vascular Endothelial Growth Factor (VEGF)-Mediated Vascular Hyperpermeability without Altering VEGF Receptor 2-Dependent Luteal Angiogenesis in a Rat Ovarian Hyperstimulation Model

Raúl Gómez, Miguel Gonzalez-Izquierdo, Ralf C. Zimmermann et al. · Endocrinology · 2006 · 158 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study

C. Carizza, V. Abdelmassih, S. Abdelmassih et al. · Reproductive BioMedicine Online · 2008 · 127 citations

Medicine, Endocrinology, Gynecology +12

Intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome in an in vitro fertilization program: a prospective, randomized, placebo-controlled study

Zeev Shoham, Ariel Weissman, Morey Schachter et al. · Fertility and Sterility · 1994 · 123 citations

Medicine, Gynecology, Obstetrics +15

Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study

Carlos Álvarez, Isabel Alonso-Muriel, G. García et al. · Human Reproduction · 2007 · 106 citations · Full text

Medicine, Gynecology, Pharmacology +15

Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study

J. Bellver · Human Reproduction · 2003 · 70 citations

Medicine, Gynecology, In Vitro Fertilization +8